首页> 外文OA文献 >Anti-CD3/Anti-Epidermal Growth Factor Receptor-Bispecific Antibody Retargeting of Lymphocytes against Human Neoplastic Keratinocytes in an Autologous Organotypic Culture Model
【2h】

Anti-CD3/Anti-Epidermal Growth Factor Receptor-Bispecific Antibody Retargeting of Lymphocytes against Human Neoplastic Keratinocytes in an Autologous Organotypic Culture Model

机译:抗CD3 /抗表皮生长因子受体-双特异性 针对人类肿瘤的淋巴细胞抗体重定位 自体器官型培养模型中的角质形成细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Local cellular immune defects have been described in severaltumors including human papillomavirus (HPV)-associated cervical cancer.This observation suggests the potential therapeutic benefit of immunemanipulations that restore cellular immunity. Here, weevaluated the ability of bispecific monoclonal antibodies (bimAbs) toredirect T cells against keratinocytes transformed invitro by HPV in an autologous three-dimensional culture model(organotypic cultures). The epidermal growth factor receptor (EGFR) waschosen as target for an anti-CD3/anti-EGFR bimAb because it isoverexpressed in many malignant epithelial lesions and only weaklyexpressed in the basal layers of normal squamous epithelium.Interestingly, in organotypic cultures, the pattern ofexpression of EGFR was similar to that observed in vivo.The ability of T cells retargeted by CD3/EGFR bimAb to lyseHPV-transformed cell lines was confirmed in monolayer cultures. Inautologous organotypic cultures, an increase in apoptoticHPV+ keratinocytes and a significant decrease in thethickness of HPV+ organotypic cultures were observed whenactivated lymphocytes and bimAbs were added to the cultures,whereas organotypic cultures of normal keratinocytes were notsignificantly affected. These data were similar to those obtained inthe allogeneic model. These results suggest the potential usefulness ofCD3-EGFR bimAb-retargeted lymphocytes in immunotherapeutic protocolsfor malignant epithelial lesions.
机译:已经在包括人类乳头瘤病毒(HPV)相关的子宫颈癌在内的多种肿瘤中描述了局部细胞免疫缺陷。这一观察结果表明,免疫操纵可恢复细胞免疫力,具有潜在的治疗益处。在这里,我们评估了双特异性单克隆抗体(bimAbs)在自体三维培养模型(有机型培养)中针对HPV体外转化的角质形成细胞重定向T细胞的能力。选择表皮生长因子受体(EGFR)作为抗CD3 /抗EGFR bimAb的靶标,因为它在许多恶性上皮病变中过表达并且仅在正常鳞状上皮的基底层中弱表达。有趣的是,在器官型培养中,表达模式在单层培养中证实了CD3 / EGFR bimAb重新定向的T细胞对lyseHPV转化的细胞系的溶解能力。在自体器官型培养物中,当将活化的淋巴细胞和bimAb加入培养物中时,观察到凋亡的HPV +角质形成细胞的增加和HPV +器官型培养物的厚度显着降低,而正常角质形成细胞的器官型培养没有受到显着影响。这些数据与在同种异体模型中获得的数据相似。这些结果表明,CD3-EGFR bimAb靶向淋巴细胞在恶性上皮病变的免疫治疗方案中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号